nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM4—epithelium—fallopian tube cancer	0.0357	0.0357	CbGeAlD
L-Glutamine—TGM5—endometrium—fallopian tube cancer	0.0222	0.0222	CbGeAlD
L-Glutamine—TGM1—uterine cervix—fallopian tube cancer	0.0199	0.0199	CbGeAlD
L-Glutamine—TGM3—uterine cervix—fallopian tube cancer	0.0186	0.0186	CbGeAlD
L-Glutamine—NADSYN1—uterine cervix—fallopian tube cancer	0.017	0.017	CbGeAlD
L-Glutamine—TGM5—vagina—fallopian tube cancer	0.0166	0.0166	CbGeAlD
L-Glutamine—TGM1—female reproductive system—fallopian tube cancer	0.0149	0.0149	CbGeAlD
L-Glutamine—TGM2—epithelium—fallopian tube cancer	0.0147	0.0147	CbGeAlD
L-Glutamine—CCBL1—endometrium—fallopian tube cancer	0.0141	0.0141	CbGeAlD
L-Glutamine—GMPS—uterine cervix—fallopian tube cancer	0.0137	0.0137	CbGeAlD
L-Glutamine—CTPS1—uterine cervix—fallopian tube cancer	0.0137	0.0137	CbGeAlD
L-Glutamine—TGM1—female gonad—fallopian tube cancer	0.0135	0.0135	CbGeAlD
L-Glutamine—TGM1—vagina—fallopian tube cancer	0.0135	0.0135	CbGeAlD
L-Glutamine—PFAS—uterine cervix—fallopian tube cancer	0.0135	0.0135	CbGeAlD
L-Glutamine—GFPT2—uterine cervix—fallopian tube cancer	0.0135	0.0135	CbGeAlD
L-Glutamine—GLS2—female reproductive system—fallopian tube cancer	0.0128	0.0128	CbGeAlD
L-Glutamine—NADSYN1—female reproductive system—fallopian tube cancer	0.0128	0.0128	CbGeAlD
L-Glutamine—TGM3—vagina—fallopian tube cancer	0.0126	0.0126	CbGeAlD
L-Glutamine—GMPS—endometrium—fallopian tube cancer	0.0124	0.0124	CbGeAlD
L-Glutamine—CTPS1—endometrium—fallopian tube cancer	0.0124	0.0124	CbGeAlD
L-Glutamine—GFPT2—endometrium—fallopian tube cancer	0.0122	0.0122	CbGeAlD
L-Glutamine—PFAS—endometrium—fallopian tube cancer	0.0122	0.0122	CbGeAlD
L-Glutamine—TGM2—uterus—fallopian tube cancer	0.0121	0.0121	CbGeAlD
L-Glutamine—F13A1—uterine cervix—fallopian tube cancer	0.0121	0.0121	CbGeAlD
L-Glutamine—GATB—female reproductive system—fallopian tube cancer	0.0117	0.0117	CbGeAlD
L-Glutamine—GLS2—female gonad—fallopian tube cancer	0.0116	0.0116	CbGeAlD
L-Glutamine—NADSYN1—female gonad—fallopian tube cancer	0.0116	0.0116	CbGeAlD
L-Glutamine—GLS2—vagina—fallopian tube cancer	0.0115	0.0115	CbGeAlD
L-Glutamine—NADSYN1—vagina—fallopian tube cancer	0.0115	0.0115	CbGeAlD
L-Glutamine—QARS—uterine cervix—fallopian tube cancer	0.0115	0.0115	CbGeAlD
L-Glutamine—CTPS1—uterus—fallopian tube cancer	0.0114	0.0114	CbGeAlD
L-Glutamine—GFPT2—uterus—fallopian tube cancer	0.0112	0.0112	CbGeAlD
L-Glutamine—GLS—female reproductive system—fallopian tube cancer	0.011	0.011	CbGeAlD
L-Glutamine—F13A1—endometrium—fallopian tube cancer	0.0109	0.0109	CbGeAlD
L-Glutamine—TGM2—female reproductive system—fallopian tube cancer	0.0109	0.0109	CbGeAlD
L-Glutamine—GATB—female gonad—fallopian tube cancer	0.0106	0.0106	CbGeAlD
L-Glutamine—CCBL1—female gonad—fallopian tube cancer	0.0106	0.0106	CbGeAlD
L-Glutamine—CAD—uterine cervix—fallopian tube cancer	0.0106	0.0106	CbGeAlD
L-Glutamine—CCBL1—vagina—fallopian tube cancer	0.0106	0.0106	CbGeAlD
L-Glutamine—GATB—vagina—fallopian tube cancer	0.0106	0.0106	CbGeAlD
L-Glutamine—QARS—endometrium—fallopian tube cancer	0.0104	0.0104	CbGeAlD
L-Glutamine—GMPS—female reproductive system—fallopian tube cancer	0.0103	0.0103	CbGeAlD
L-Glutamine—CTPS1—female reproductive system—fallopian tube cancer	0.0103	0.0103	CbGeAlD
L-Glutamine—GFPT2—female reproductive system—fallopian tube cancer	0.0101	0.0101	CbGeAlD
L-Glutamine—PFAS—female reproductive system—fallopian tube cancer	0.0101	0.0101	CbGeAlD
L-Glutamine—F13A1—uterus—fallopian tube cancer	0.0101	0.0101	CbGeAlD
L-Glutamine—GLS—female gonad—fallopian tube cancer	0.01	0.01	CbGeAlD
L-Glutamine—GLS—vagina—fallopian tube cancer	0.00997	0.00997	CbGeAlD
L-Glutamine—TGM2—female gonad—fallopian tube cancer	0.00992	0.00992	CbGeAlD
L-Glutamine—PPAT—uterine cervix—fallopian tube cancer	0.00981	0.00981	CbGeAlD
L-Glutamine—CAD—endometrium—fallopian tube cancer	0.00957	0.00957	CbGeAlD
L-Glutamine—QARS—uterus—fallopian tube cancer	0.00956	0.00956	CbGeAlD
L-Glutamine—GMPS—female gonad—fallopian tube cancer	0.00934	0.00934	CbGeAlD
L-Glutamine—CTPS1—female gonad—fallopian tube cancer	0.00934	0.00934	CbGeAlD
L-Glutamine—CTPS1—vagina—fallopian tube cancer	0.00928	0.00928	CbGeAlD
L-Glutamine—GMPS—vagina—fallopian tube cancer	0.00928	0.00928	CbGeAlD
L-Glutamine—PFAS—female gonad—fallopian tube cancer	0.00917	0.00917	CbGeAlD
L-Glutamine—GFPT2—female gonad—fallopian tube cancer	0.00917	0.00917	CbGeAlD
L-Glutamine—SLC1A5—epithelium—fallopian tube cancer	0.00917	0.00917	CbGeAlD
L-Glutamine—PFAS—vagina—fallopian tube cancer	0.00912	0.00912	CbGeAlD
L-Glutamine—GFPT2—vagina—fallopian tube cancer	0.00912	0.00912	CbGeAlD
L-Glutamine—SLC1A5—uterine cervix—fallopian tube cancer	0.00909	0.00909	CbGeAlD
L-Glutamine—F13A1—female reproductive system—fallopian tube cancer	0.00904	0.00904	CbGeAlD
L-Glutamine—PPAT—endometrium—fallopian tube cancer	0.00888	0.00888	CbGeAlD
L-Glutamine—CAD—uterus—fallopian tube cancer	0.00882	0.00882	CbGeAlD
L-Glutamine—QARS—female reproductive system—fallopian tube cancer	0.0086	0.0086	CbGeAlD
L-Glutamine—F13A1—female gonad—fallopian tube cancer	0.00823	0.00823	CbGeAlD
L-Glutamine—SLC1A5—endometrium—fallopian tube cancer	0.00822	0.00822	CbGeAlD
L-Glutamine—F13A1—vagina—fallopian tube cancer	0.00818	0.00818	CbGeAlD
L-Glutamine—CAD—female reproductive system—fallopian tube cancer	0.00793	0.00793	CbGeAlD
L-Glutamine—QARS—female gonad—fallopian tube cancer	0.00782	0.00782	CbGeAlD
L-Glutamine—ASNS—uterine cervix—fallopian tube cancer	0.0078	0.0078	CbGeAlD
L-Glutamine—QARS—vagina—fallopian tube cancer	0.00777	0.00777	CbGeAlD
L-Glutamine—SLC1A5—uterus—fallopian tube cancer	0.00757	0.00757	CbGeAlD
L-Glutamine—PPAT—female reproductive system—fallopian tube cancer	0.00735	0.00735	CbGeAlD
L-Glutamine—CAD—female gonad—fallopian tube cancer	0.00721	0.00721	CbGeAlD
L-Glutamine—CAD—vagina—fallopian tube cancer	0.00717	0.00717	CbGeAlD
L-Glutamine—ASNS—endometrium—fallopian tube cancer	0.00705	0.00705	CbGeAlD
L-Glutamine—SLC1A5—female reproductive system—fallopian tube cancer	0.00681	0.00681	CbGeAlD
L-Glutamine—PPAT—female gonad—fallopian tube cancer	0.00669	0.00669	CbGeAlD
L-Glutamine—PPAT—vagina—fallopian tube cancer	0.00665	0.00665	CbGeAlD
L-Glutamine—ASNS—uterus—fallopian tube cancer	0.0065	0.0065	CbGeAlD
L-Glutamine—GLUL—epithelium—fallopian tube cancer	0.00642	0.00642	CbGeAlD
L-Glutamine—GLUL—uterine cervix—fallopian tube cancer	0.00637	0.00637	CbGeAlD
L-Glutamine—SLC1A5—female gonad—fallopian tube cancer	0.0062	0.0062	CbGeAlD
L-Glutamine—SLC1A5—vagina—fallopian tube cancer	0.00616	0.00616	CbGeAlD
L-Glutamine—SLC7A8—female reproductive system—fallopian tube cancer	0.00613	0.00613	CbGeAlD
L-Glutamine—GLUL—endometrium—fallopian tube cancer	0.00576	0.00576	CbGeAlD
L-Glutamine—SLC7A8—female gonad—fallopian tube cancer	0.00558	0.00558	CbGeAlD
L-Glutamine—SLC7A8—vagina—fallopian tube cancer	0.00554	0.00554	CbGeAlD
L-Glutamine—ASNS—female gonad—fallopian tube cancer	0.00532	0.00532	CbGeAlD
L-Glutamine—GLUL—uterus—fallopian tube cancer	0.00531	0.00531	CbGeAlD
L-Glutamine—ASNS—vagina—fallopian tube cancer	0.00528	0.00528	CbGeAlD
L-Glutamine—SLC16A10—epithelium—fallopian tube cancer	0.0049	0.0049	CbGeAlD
L-Glutamine—GLUL—female reproductive system—fallopian tube cancer	0.00477	0.00477	CbGeAlD
L-Glutamine—GLUL—female gonad—fallopian tube cancer	0.00434	0.00434	CbGeAlD
L-Glutamine—GLUL—vagina—fallopian tube cancer	0.00431	0.00431	CbGeAlD
L-Glutamine—SLC16A10—female reproductive system—fallopian tube cancer	0.00364	0.00364	CbGeAlD
L-Glutamine—SLC16A10—vagina—fallopian tube cancer	0.00329	0.00329	CbGeAlD
